StabilityStudies.in
Standard Operating Procedure for Stability Testing of Controlled-Temperature Drug Products
1) Purpose
The purpose of this SOP is to provide a standard procedure for conducting stability studies on drug products that require controlled-temperature storage conditions, ensuring they maintain their quality, safety, and efficacy throughout their shelf life.
2) Scope
This SOP applies to all drug products that require controlled-temperature storage, such as those stored at refrigerated or frozen conditions. It is relevant to the departments involved in manufacturing, quality control, quality assurance, and regulatory compliance.
3) Responsibilities
- Quality Control (QC) Team: Conducts stability testing and documents results.
- Quality Assurance (QA)
Team: Ensures compliance with this SOP and regulatory guidelines.
Production Team: Provides the required samples for testing and maintains batch records.
4) Procedure
- Sample Preparation
- Identify the drug products requiring controlled-temperature storage.
- Collect representative samples from production batches.
- Stability Study Protocol Development
- Draft a stability study protocol outlining storage conditions (e.g., 2-8°C, -20°C), test intervals, and analytical methods.
- Submit the protocol for approval by the QA and Regulatory Affairs teams.
- Execution of Stability Study
- Store samples in controlled-temperature chambers at specified conditions.
- Perform analytical tests at each interval to assess stability parameters, including potency, purity, and appearance.
- Record and document all findings, test results, and deviations from the protocol.
- Data Analysis and Reporting
- Analyze data to determine if the product remains stable under the specified controlled-temperature conditions.
- Prepare a comprehensive report and submit it to the QA team for review and approval.
5) Abbreviations, if any
- QC: Quality Control
- QA: Quality Assurance
6) Documents, if any
- Stability Study Protocol
- Analytical Test Reports
- Stability Study Report
7) Reference, if any
- ICH Q1A(R2): Stability Testing of New Drug Substances and Products
- WHO Technical Report Series No. 953: Annex 2, Stability Testing of Active Pharmaceutical Ingredients and Finished Pharmaceutical Products
8) SOP Version
Version 1.0
StabilityStudies.in